219 related articles for article (PubMed ID: 6142096)
1. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
[TBL] [Abstract][Full Text] [Related]
2. Lack of cholinergic deficit in the neocortex in Pick's disease.
Wood PL; Nair NP; Etienne P; Lal S; Gauthier S; Robitaille Y; Bird ED; Palo J; Haltia M; Paetau A
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):725-7. PubMed ID: 6141615
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical observations in a case of Pick's disease.
Yates CM; Simpson J; Maloney AF; Gordon A
J Neurol Sci; 1980 Nov; 48(2):257-63. PubMed ID: 7431041
[TBL] [Abstract][Full Text] [Related]
4. Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
Hansen LA; Deteresa R; Tobias H; Alford M; Terry RD
Am J Pathol; 1988 Jun; 131(3):507-18. PubMed ID: 3381880
[TBL] [Abstract][Full Text] [Related]
5. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
[TBL] [Abstract][Full Text] [Related]
6. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
[TBL] [Abstract][Full Text] [Related]
8. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
Mash DC; Flynn DD; Potter LT
Science; 1985 May; 228(4703):1115-7. PubMed ID: 3992249
[TBL] [Abstract][Full Text] [Related]
9. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Davies P; Katzman R; Terry RD
Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
Ruberg M; Ploska A; Javoy-Agid F; Agid Y
Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
[TBL] [Abstract][Full Text] [Related]
11. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
12. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
[TBL] [Abstract][Full Text] [Related]
13. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Morrison JH
Acta Neuropathol; 1994; 87(2):115-24. PubMed ID: 8171960
[TBL] [Abstract][Full Text] [Related]
14. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.
Potter PE; Rauschkolb PK; Pandya Y; Sue LI; Sabbagh MN; Walker DG; Beach TG
Acta Neuropathol; 2011 Jul; 122(1):49-60. PubMed ID: 21533854
[TBL] [Abstract][Full Text] [Related]
16. Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.
Geula C; Dunlop SR; Ayala I; Kawles AS; Flanagan ME; Gefen T; Mesulam MM
J Neurochem; 2021 Sep; 158(6):1394-1411. PubMed ID: 34272732
[TBL] [Abstract][Full Text] [Related]
17. Neuronal RNA in Pick's and Alzheimer's diseases. Comparison of disease-susceptible and disease-resistant cortical areas.
Doebler JA; Rhoads RE; Anthony A; Markesbery WR
Arch Neurol; 1989 Feb; 46(2):134-7. PubMed ID: 2464984
[TBL] [Abstract][Full Text] [Related]
18. Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease.
Clark AW; Manz HJ; White CL; Lehmann J; Miller D; Coyle JT
J Neuropathol Exp Neurol; 1986 May; 45(3):268-84. PubMed ID: 3958759
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Perry EK; Smith CJ; Court JA; Perry RH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
[TBL] [Abstract][Full Text] [Related]
20. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Sparks DL; Markesbery WR
Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
